Survival of Highly Sensitized Patients on the Waiting List for Kidney Transplantation at Modena Transplant Center

HLA sensitization plays a pivotal role in kidney transplantation. The presence of anti HLA antibodies strongly limits access to transplantation to subjects on the waiting list, particularly for highly sensitized patients. The aim of this study is to evaluate the waiting time of highly sensitized can...

Full description

Saved in:
Bibliographic Details
Published inTransplantation proceedings Vol. 57; no. 6; pp. 975 - 981
Main Authors Mori, Giacomo, Plessi, Jessica, Morisi, Niccolò, Tonelli, Laura, Melara, Laura, Oliviero, Giuseppe, Parmigiani, Alice, Ferrarini, Marco, Di Sandro, Stefano, Donati, Gabriele
Format Journal Article
LanguageEnglish
Published United States Elsevier Inc 01.07.2025
Subjects
Online AccessGet full text
ISSN0041-1345
1873-2623
1873-2623
DOI10.1016/j.transproceed.2025.04.010

Cover

Loading…
Abstract HLA sensitization plays a pivotal role in kidney transplantation. The presence of anti HLA antibodies strongly limits access to transplantation to subjects on the waiting list, particularly for highly sensitized patients. The aim of this study is to evaluate the waiting time of highly sensitized candidates, when compared with patients with a lower level of sensitization, and the respective survival rates on the waiting list. We conducted a single center retrospective observational study stratified according to calculated panel reactive antibodies (cPRAs) in highly sensitized patients (cPRA ≥ 80%) and patients with a lower level of sensitization (NH; cPRA < 80%). A total of 911 patients on the waiting list were considered. Survival analysis was performed according to Kaplan Meier, and multivariate analysis was performed with Cox regression. Mortality data were collected only for 222 patients who were residents in the Province of Modena, Italy. Highly sensitized subjects have a significantly longer waiting time from enrollment to kidney transplantation when compared to patients with a lower level of sensitization, but in our highly sensitized patients the mortality rate resulted slightly lower because of the protective effect of a younger age at enrollment. Highly sensitized patients wait longer to achieve kidney transplantation, but they do not show worse survival rates, likely because of a younger age at enrollment. These results highlight the importance of innovative strategies to allow access to transplantation to highly sensitive subjects to limit the personal and social cost of a prolonged stay on dialysis.
AbstractList HLA sensitization plays a pivotal role in kidney transplantation. The presence of anti HLA antibodies strongly limits access to transplantation to subjects on the waiting list, particularly for highly sensitized patients. The aim of this study is to evaluate the waiting time of highly sensitized candidates, when compared with patients with a lower level of sensitization, and the respective survival rates on the waiting list. We conducted a single center retrospective observational study stratified according to calculated panel reactive antibodies (cPRAs) in highly sensitized patients (cPRA ≥ 80%) and patients with a lower level of sensitization (NH; cPRA < 80%). A total of 911 patients on the waiting list were considered. Survival analysis was performed according to Kaplan Meier, and multivariate analysis was performed with Cox regression. Mortality data were collected only for 222 patients who were residents in the Province of Modena, Italy. Highly sensitized subjects have a significantly longer waiting time from enrollment to kidney transplantation when compared to patients with a lower level of sensitization, but in our highly sensitized patients the mortality rate resulted slightly lower because of the protective effect of a younger age at enrollment. Highly sensitized patients wait longer to achieve kidney transplantation, but they do not show worse survival rates, likely because of a younger age at enrollment. These results highlight the importance of innovative strategies to allow access to transplantation to highly sensitive subjects to limit the personal and social cost of a prolonged stay on dialysis.
HLA sensitization plays a pivotal role in kidney transplantation. The presence of anti HLA antibodies strongly limits access to transplantation to subjects on the waiting list, particularly for highly sensitized patients. The aim of this study is to evaluate the waiting time of highly sensitized candidates, when compared with patients with a lower level of sensitization, and the respective survival rates on the waiting list.BACKGROUNDHLA sensitization plays a pivotal role in kidney transplantation. The presence of anti HLA antibodies strongly limits access to transplantation to subjects on the waiting list, particularly for highly sensitized patients. The aim of this study is to evaluate the waiting time of highly sensitized candidates, when compared with patients with a lower level of sensitization, and the respective survival rates on the waiting list.We conducted a single center retrospective observational study stratified according to calculated panel reactive antibodies (cPRAs) in highly sensitized patients (cPRA ≥ 80%) and patients with a lower level of sensitization (NH; cPRA < 80%). A total of 911 patients on the waiting list were considered. Survival analysis was performed according to Kaplan Meier, and multivariate analysis was performed with Cox regression. Mortality data were collected only for 222 patients who were residents in the Province of Modena, Italy.METHODSWe conducted a single center retrospective observational study stratified according to calculated panel reactive antibodies (cPRAs) in highly sensitized patients (cPRA ≥ 80%) and patients with a lower level of sensitization (NH; cPRA < 80%). A total of 911 patients on the waiting list were considered. Survival analysis was performed according to Kaplan Meier, and multivariate analysis was performed with Cox regression. Mortality data were collected only for 222 patients who were residents in the Province of Modena, Italy.Highly sensitized subjects have a significantly longer waiting time from enrollment to kidney transplantation when compared to patients with a lower level of sensitization, but in our highly sensitized patients the mortality rate resulted slightly lower because of the protective effect of a younger age at enrollment.RESULTSHighly sensitized subjects have a significantly longer waiting time from enrollment to kidney transplantation when compared to patients with a lower level of sensitization, but in our highly sensitized patients the mortality rate resulted slightly lower because of the protective effect of a younger age at enrollment.Highly sensitized patients wait longer to achieve kidney transplantation, but they do not show worse survival rates, likely because of a younger age at enrollment. These results highlight the importance of innovative strategies to allow access to transplantation to highly sensitive subjects to limit the personal and social cost of a prolonged stay on dialysis.CONCLUSIONSHighly sensitized patients wait longer to achieve kidney transplantation, but they do not show worse survival rates, likely because of a younger age at enrollment. These results highlight the importance of innovative strategies to allow access to transplantation to highly sensitive subjects to limit the personal and social cost of a prolonged stay on dialysis.
Author Ferrarini, Marco
Tonelli, Laura
Parmigiani, Alice
Di Sandro, Stefano
Donati, Gabriele
Oliviero, Giuseppe
Melara, Laura
Mori, Giacomo
Plessi, Jessica
Morisi, Niccolò
Author_xml – sequence: 1
  givenname: Giacomo
  surname: Mori
  fullname: Mori, Giacomo
  organization: Nephrology, Dialysis, and Kidney Transplant Unit, Azienda Ospedaliero-Universitaria di Modena, Italy
– sequence: 2
  givenname: Jessica
  surname: Plessi
  fullname: Plessi, Jessica
  organization: Surgical, Medical, and Dental Department of Morphological Sciences related to Transplant, Oncology and Regenerative Medicine (CHIMOMO), University of Modena and Reggio Emilia, Modena, Italy
– sequence: 3
  givenname: Niccolò
  surname: Morisi
  fullname: Morisi, Niccolò
  organization: Nephrology, Dialysis, and Kidney Transplant Unit, Azienda Ospedaliero-Universitaria di Modena, Italy
– sequence: 4
  givenname: Laura
  surname: Tonelli
  fullname: Tonelli, Laura
  organization: Surgical, Medical, and Dental Department of Morphological Sciences related to Transplant, Oncology and Regenerative Medicine (CHIMOMO), University of Modena and Reggio Emilia, Modena, Italy
– sequence: 5
  givenname: Laura
  surname: Melara
  fullname: Melara, Laura
  organization: Surgical, Medical, and Dental Department of Morphological Sciences related to Transplant, Oncology and Regenerative Medicine (CHIMOMO), University of Modena and Reggio Emilia, Modena, Italy
– sequence: 6
  givenname: Giuseppe
  surname: Oliviero
  fullname: Oliviero, Giuseppe
  organization: Surgical, Medical, and Dental Department of Morphological Sciences related to Transplant, Oncology and Regenerative Medicine (CHIMOMO), University of Modena and Reggio Emilia, Modena, Italy
– sequence: 7
  givenname: Alice
  surname: Parmigiani
  fullname: Parmigiani, Alice
  organization: Nephrology, Dialysis, and Kidney Transplant Unit, Azienda Ospedaliero-Universitaria di Modena, Italy
– sequence: 8
  givenname: Marco
  surname: Ferrarini
  fullname: Ferrarini, Marco
  organization: Surgical, Medical, and Dental Department of Morphological Sciences related to Transplant, Oncology and Regenerative Medicine (CHIMOMO), University of Modena and Reggio Emilia, Modena, Italy
– sequence: 9
  givenname: Stefano
  surname: Di Sandro
  fullname: Di Sandro, Stefano
  organization: Hepato-Pancreato-Biliary Surgery and Liver Transplantation Unit, Azienda Ospedaliero-Universitaria di Modena, Italy
– sequence: 10
  givenname: Gabriele
  orcidid: 0000-0001-8549-1221
  surname: Donati
  fullname: Donati, Gabriele
  email: gabriele.donati@unimore.it
  organization: Nephrology, Dialysis, and Kidney Transplant Unit, Azienda Ospedaliero-Universitaria di Modena, Italy
BackLink https://www.ncbi.nlm.nih.gov/pubmed/40562598$$D View this record in MEDLINE/PubMed
BookMark eNqNkUtPGzEUha0KBOHxFyqrq25mev2YyaS7NrRQEdRKRGJpOfYdcDqxwXYipb--htAKsWJlWfc7R_eec0T2fPBIyAcGNQPWflrWOWqf7mMwiLbmwJsaZA0M3pER68ai4i0Xe2QEIFnFhGwOyVFKSyh_LsUBOZTQtLyZdCPycL2OG7fRAw09vXC3d8OWXqNPLrs_aOkvnR36nGjwNN8hvdFl4G_pzKVM-xDppbMet3T-tNCgfS6CwupMr4JFr19M6LQ4YTwh-70eEp4-v8dk_v3bfHpRzX6e_5h-mVVGNAwqBl2DFrXQYy6AT8AyaM3Y9B2yBV_0bKGlaUUPBrXBpmtZx7SZdBNmGFgtjsnHnW2J6WGNKauVSwaHsgmGdVKCc8mbVshxQd8_o-vFCq26j26l41b9S6kAn3eAiSGliP1_hIF6rEQt1ctK1GMlCqQqlRTx2U6M5diNw6iSKZkatC6iycoG9zabr69szOC8M3r4jdu3mvwFzQezlw
Cites_doi 10.1034/j.1600-6143.2003.00135.x
10.1097/TP.0b013e31827a19cc
10.1056/NEJM196904032801401
10.3390/nu12051234
10.1093/ndt/gfu212
10.1056/NEJMoa1012376
10.1097/00007890-200204270-00014
10.1016/j.transproceed.2004.08.137
10.1016/S0198-8859(97)00187-0
10.1111/ctr.12289
10.3389/ti.2022.10511
10.1016/j.kint.2017.07.018
10.1016/j.crimmu.2023.100056
10.1111/j.1399-0012.2006.00578.x
10.3389/fimmu.2021.687254
10.1080/14712598.2021.1850685
10.1097/TP.0000000000004238
10.1016/j.trim.2021.101441
10.1111/ajt.15486
10.1111/j.1600-6143.2009.02927.x
ContentType Journal Article
Copyright 2025 The Author(s)
Copyright © 2025 The Author(s). Published by Elsevier Inc. All rights reserved.
Copyright_xml – notice: 2025 The Author(s)
– notice: Copyright © 2025 The Author(s). Published by Elsevier Inc. All rights reserved.
DBID 6I.
AAFTH
AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
DOI 10.1016/j.transproceed.2025.04.010
DatabaseName ScienceDirect Open Access Titles
Elsevier:ScienceDirect:Open Access
CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList

MEDLINE - Academic
MEDLINE
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Anatomy & Physiology
Biology
Pharmacy, Therapeutics, & Pharmacology
EISSN 1873-2623
EndPage 981
ExternalDocumentID 40562598
10_1016_j_transproceed_2025_04_010
S0041134525002799
Genre Journal Article
Observational Study
GeographicLocations Italy
GeographicLocations_xml – name: Italy
GroupedDBID ---
--K
--M
.1-
.55
.FO
.GJ
.~1
0R~
123
1B1
1P~
1~.
1~5
29Q
3O-
4.4
457
4G.
53G
5RE
5VS
7-5
71M
8P~
AABNK
AAEDT
AAEDW
AAIKJ
AAKOC
AALRI
AAOAW
AAQFI
AAQXK
AATTM
AAXKI
AAXUO
AAYWO
ABBQC
ABFRF
ABJNI
ABLJU
ABMAC
ABMZM
ABOCM
ABWVN
ABXDB
ACDAQ
ACGFO
ACIEU
ACIUM
ACRLP
ACRPL
ACVFH
ADBBV
ADCNI
ADEZE
ADMUD
ADNMO
AEBSH
AEFWE
AEIPS
AEKER
AENEX
AEUPX
AEVXI
AFJKZ
AFPUW
AFRHN
AFTJW
AFXIZ
AGCQF
AGHFR
AGQPQ
AGUBO
AGYEJ
AIEXJ
AIGII
AIIUN
AIKHN
AITUG
AJRQY
AJUYK
AKBMS
AKRWK
AKYEP
ALMA_UNASSIGNED_HOLDINGS
AMRAJ
ANKPU
ANZVX
APXCP
ASPBG
AVWKF
AXJTR
AZFZN
BKOJK
BLXMC
BNPGV
CS3
DU5
EBS
EFJIC
EFKBS
EJD
EO8
EO9
EP2
EP3
F5P
FDB
FEDTE
FGOYB
FIRID
FNPLU
FYGXN
G-Q
GBLVA
HVGLF
HZ~
IHE
J1W
J5H
K-O
KOM
L7B
M41
MO0
N9A
O-L
O9-
OAUVE
OK-
OW-
OZT
P-8
P-9
P2P
PC.
Q38
R2-
ROL
RPZ
SCC
SDF
SDG
SDP
SEL
SES
SEW
SPCBC
SSH
SSZ
T5K
UDS
WH7
X7M
XPP
Y6R
Z5R
ZGI
ZXP
~G-
6I.
AAFTH
AAYXX
AFCTW
AGRNS
CITATION
RIG
CGR
CUY
CVF
ECM
EIF
NPM
7X8
ID FETCH-LOGICAL-c3510-1085edea3a7230290d106c7cf8e1b2bf1ba4c63f0ceace586181ac9891c10da3
IEDL.DBID .~1
ISSN 0041-1345
1873-2623
IngestDate Thu Jun 26 16:31:02 EDT 2025
Tue Jul 29 01:38:22 EDT 2025
Thu Jul 31 00:11:52 EDT 2025
Sat Aug 23 17:12:44 EDT 2025
Tue Aug 26 16:32:07 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 6
Language English
License This is an open access article under the CC BY license.
Copyright © 2025 The Author(s). Published by Elsevier Inc. All rights reserved.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c3510-1085edea3a7230290d106c7cf8e1b2bf1ba4c63f0ceace586181ac9891c10da3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ORCID 0000-0001-8549-1221
OpenAccessLink https://www.sciencedirect.com/science/article/pii/S0041134525002799
PMID 40562598
PQID 3224256347
PQPubID 23479
PageCount 7
ParticipantIDs proquest_miscellaneous_3224256347
pubmed_primary_40562598
crossref_primary_10_1016_j_transproceed_2025_04_010
elsevier_sciencedirect_doi_10_1016_j_transproceed_2025_04_010
elsevier_clinicalkey_doi_10_1016_j_transproceed_2025_04_010
PublicationCentury 2000
PublicationDate 2025-07-01
PublicationDateYYYYMMDD 2025-07-01
PublicationDate_xml – month: 07
  year: 2025
  text: 2025-07-01
  day: 01
PublicationDecade 2020
PublicationPlace United States
PublicationPlace_xml – name: United States
PublicationTitle Transplantation proceedings
PublicationTitleAlternate Transplant Proc
PublicationYear 2025
Publisher Elsevier Inc
Publisher_xml – name: Elsevier Inc
References Attività Annuale Rete Nazionale Trapianti. Centro Nazionale Trapianti. Report 2021.
Zecher, Zeman, Drasch, Tieken, Heidt, Haasnoot (bib0020) 2022; 106
Cappuccilli, Bergamini, Giacomelli, Cianciolo, Donati, Conte (bib0024) 2020; 12
Cecka (bib0008) 2010; 10
Heidt, Haasnoot, van Rood, Witvliet, Claas (bib0018) 2018; 93
Heidt, Haasnoot, van der Linden-van Oevelen, Claas (bib0021) 2021; 12
Accessed March 16, 2023.
Perosa, Ferreira, Modelli, Medeiros, Neto, Moreira (bib0016) 2021; 68
Cangini, Rusolo, Cappuccilli, Donati, La Manna (bib0023) 2019; 170
Grimaldi, Pagano, Moccia, Maiello, De, Napoli (bib0011) 2023; 4
Patel, Terasaki (bib0007) 1969; 280
Protocollo Nazionale Iperimmuni - Istituto Superiore di Sanità - Centro Nazionale Trapianti
Accessed April 1, 2023.
OPTN Policies Effective
Mamode, Bestard, Claas, Furian, Griffin, Legendre (bib0012) 2022; 35
Maggiore, Oberbauer, Pascual, Viklicky, Dudley, Budde (bib0025) 2015; 30
Süsal, Opelz (bib0003) 2002; 73
Terasaki (bib0005) 2003; 3
Montgomery, Lonze, King, Kraus, Kucirka, Locke (bib0017) 2011; 365
Lonze (bib0026) 2021; 21
Eurotransplant Manual - chapter 10: histocompatibility testing.
Lee, Kim, Lee, Lee, Joh, Lee (bib0004) 2004; 36
Tait, Süsal, Gebel, Nickerson, Zachary, Claas (bib0009) 2013; 95
Cecka (bib0002) 1997; 56
Gloor (bib0006) 2005; 146
Yoo, Bonnel, Kamoun, Levine (bib0010) 2014; 28
Heidt, Haasnoot, Witvliet, van der Linden-van Oevelen, Kamburova, Wisse (bib0019) 2019; 19
Barocci, Valente, Nocera (bib0001) 2007; 21
Tait (10.1016/j.transproceed.2025.04.010_bib0009) 2013; 95
Mamode (10.1016/j.transproceed.2025.04.010_bib0012) 2022; 35
Heidt (10.1016/j.transproceed.2025.04.010_bib0019) 2019; 19
Perosa (10.1016/j.transproceed.2025.04.010_bib0016) 2021; 68
Maggiore (10.1016/j.transproceed.2025.04.010_bib0025) 2015; 30
Terasaki (10.1016/j.transproceed.2025.04.010_bib0005) 2003; 3
10.1016/j.transproceed.2025.04.010_bib0022
Patel (10.1016/j.transproceed.2025.04.010_bib0007) 1969; 280
Cecka (10.1016/j.transproceed.2025.04.010_bib0008) 2010; 10
Barocci (10.1016/j.transproceed.2025.04.010_bib0001) 2007; 21
Süsal (10.1016/j.transproceed.2025.04.010_bib0003) 2002; 73
Lonze (10.1016/j.transproceed.2025.04.010_bib0026) 2021; 21
Gloor (10.1016/j.transproceed.2025.04.010_bib0006) 2005; 146
10.1016/j.transproceed.2025.04.010_bib0015
10.1016/j.transproceed.2025.04.010_bib0013
Heidt (10.1016/j.transproceed.2025.04.010_bib0018) 2018; 93
10.1016/j.transproceed.2025.04.010_bib0014
Cecka (10.1016/j.transproceed.2025.04.010_bib0002) 1997; 56
Cangini (10.1016/j.transproceed.2025.04.010_bib0023) 2019; 170
Heidt (10.1016/j.transproceed.2025.04.010_bib0021) 2021; 12
Grimaldi (10.1016/j.transproceed.2025.04.010_bib0011) 2023; 4
Cappuccilli (10.1016/j.transproceed.2025.04.010_bib0024) 2020; 12
Lee (10.1016/j.transproceed.2025.04.010_bib0004) 2004; 36
Zecher (10.1016/j.transproceed.2025.04.010_bib0020) 2022; 106
Montgomery (10.1016/j.transproceed.2025.04.010_bib0017) 2011; 365
Yoo (10.1016/j.transproceed.2025.04.010_bib0010) 2014; 28
References_xml – volume: 56
  start-page: 6
  year: 1997
  end-page: 16
  ident: bib0002
  article-title: The role of HLA in renal transplantation
  publication-title: Hum Immunol
– reference: Eurotransplant Manual - chapter 10: histocompatibility testing.
– volume: 73
  start-page: 1269
  year: 2002
  end-page: 1273
  ident: bib0003
  article-title: Kidney graft failure and presensitization against HLA class I and class II antigens
  publication-title: Transplantation
– volume: 3
  start-page: 665
  year: 2003
  end-page: 673
  ident: bib0005
  article-title: Humoral theory of transplantation
  publication-title: Am J Transplant
– volume: 12
  year: 2021
  ident: bib0021
  article-title: Highly sensitized patients are well served by receiving a compatible organ offer based on acceptable mismatches
  publication-title: Front Immunol
– reference: Protocollo Nazionale Iperimmuni - Istituto Superiore di Sanità - Centro Nazionale Trapianti
– reference: OPTN Policies Effective
– volume: 4
  year: 2023
  ident: bib0011
  article-title: Novel insights in the clinical management of highly sensitized patients before and after transplantation
  publication-title: Curr Res Immunol
– volume: 146
  start-page: 11
  year: 2005
  end-page: 21
  ident: bib0006
  article-title: Kidney transplantation in the hyperimmunized patient
  publication-title: Contrib Nephrol
– volume: 28
  start-page: 127
  year: 2014
  end-page: 133
  ident: bib0010
  article-title: Clinical outcomes among renal transplant recipients with pre-transplant weakly reactive donor-specific antibodies
  publication-title: Clin Transplant
– reference: Attività Annuale Rete Nazionale Trapianti. Centro Nazionale Trapianti. Report 2021.
– reference: . Accessed March 16, 2023.
– volume: 10
  start-page: 26
  year: 2010
  end-page: 29
  ident: bib0008
  article-title: Calculated PRA (CPRA): the new measure of sensitization for transplant candidates
  publication-title: Am J Transplant
– volume: 36
  start-page: 2009
  year: 2004
  end-page: 2010
  ident: bib0004
  article-title: Effect of panel-reactive antibody positivity on graft rejection before or after kidney transplantation
  publication-title: Transplant Proc
– volume: 106
  start-page: 2448
  year: 2022
  end-page: 2455
  ident: bib0020
  article-title: Impact of sensitization on waiting time prior to kidney transplantation in Germany
  publication-title: Transplantation
– volume: 21
  start-page: 135
  year: 2021
  end-page: 143
  ident: bib0026
  article-title: A review of imlifidase in solid organ transplantation
  publication-title: Expert Opin Biol Ther
– volume: 280
  start-page: 735
  year: 1969
  end-page: 739
  ident: bib0007
  article-title: Significance of the positive crossmatch test in kidney transplantation
  publication-title: N Engl J Med
– volume: 95
  start-page: 19
  year: 2013
  end-page: 47
  ident: bib0009
  article-title: Consensus guidelines on the testing and clinical management issues associated with HLA and non-HLA antibodies in transplantation
  publication-title: Transplantation
– volume: 12
  start-page: 1234
  year: 2020
  ident: bib0024
  article-title: Vitamin B supplementation and nutritional intake of methyl donors in patients with chronic kidney disease: a critical review of the impact on epigenetic machinery
  publication-title: Nutrients
– volume: 365
  start-page: 318
  year: 2011
  end-page: 326
  ident: bib0017
  article-title: Desensitization in HLA-incompatible kidney recipients and survival
  publication-title: N Engl J Med
– volume: 170
  start-page: e301
  year: 2019
  end-page: e320
  ident: bib0023
  article-title: Evolution of the concept of quality of life in the population in end stage renal disease. A systematic review of the literature
  publication-title: Clin Ter
– reference: . Accessed April 1, 2023.
– volume: 93
  start-page: 491
  year: 2018
  end-page: 500
  ident: bib0018
  article-title: Kidney allocation based on proven acceptable antigens results in superior graft survival in highly sensitized patients
  publication-title: Kidney Int
– volume: 19
  start-page: 2926
  year: 2019
  end-page: 2933
  ident: bib0019
  article-title: Allocation to highly sensitized patients based on acceptable mismatches results in low rejection rates comparable to non-highly sensitized patients
  publication-title: Am J Transplant
– volume: 21
  year: 2007
  ident: bib0001
  article-title: Detection and analysis of HLA class I and class II specific alloantibodies in the sera of dialysis recipients waiting for a renal retransplantation
  publication-title: Clin Transplant
– volume: 68
  year: 2021
  ident: bib0016
  article-title: Disparity in the access to kidney transplantation for highly sensitized patients in the state of Sao Paulo-Brazil
  publication-title: Transpl Immunol
– volume: 30
  start-page: 217
  year: 2015
  end-page: 222
  ident: bib0025
  article-title: Strategies to increase the donor pool and access to kidney transplantation: an international perspective
  publication-title: Nephrol Dial Transplant
– volume: 35
  year: 2022
  ident: bib0012
  article-title: European Guideline for the Management of kidney Transplant patients with HLA antibodies: by the European Society for Organ Transplantation Working Group
  publication-title: Transpl Int
– volume: 3
  start-page: 665
  year: 2003
  ident: 10.1016/j.transproceed.2025.04.010_bib0005
  article-title: Humoral theory of transplantation
  publication-title: Am J Transplant
  doi: 10.1034/j.1600-6143.2003.00135.x
– volume: 95
  start-page: 19
  year: 2013
  ident: 10.1016/j.transproceed.2025.04.010_bib0009
  article-title: Consensus guidelines on the testing and clinical management issues associated with HLA and non-HLA antibodies in transplantation
  publication-title: Transplantation
  doi: 10.1097/TP.0b013e31827a19cc
– ident: 10.1016/j.transproceed.2025.04.010_bib0013
– volume: 280
  start-page: 735
  year: 1969
  ident: 10.1016/j.transproceed.2025.04.010_bib0007
  article-title: Significance of the positive crossmatch test in kidney transplantation
  publication-title: N Engl J Med
  doi: 10.1056/NEJM196904032801401
– ident: 10.1016/j.transproceed.2025.04.010_bib0015
– volume: 12
  start-page: 1234
  year: 2020
  ident: 10.1016/j.transproceed.2025.04.010_bib0024
  article-title: Vitamin B supplementation and nutritional intake of methyl donors in patients with chronic kidney disease: a critical review of the impact on epigenetic machinery
  publication-title: Nutrients
  doi: 10.3390/nu12051234
– volume: 30
  start-page: 217
  year: 2015
  ident: 10.1016/j.transproceed.2025.04.010_bib0025
  article-title: Strategies to increase the donor pool and access to kidney transplantation: an international perspective
  publication-title: Nephrol Dial Transplant
  doi: 10.1093/ndt/gfu212
– volume: 365
  start-page: 318
  year: 2011
  ident: 10.1016/j.transproceed.2025.04.010_bib0017
  article-title: Desensitization in HLA-incompatible kidney recipients and survival
  publication-title: N Engl J Med
  doi: 10.1056/NEJMoa1012376
– volume: 170
  start-page: e301
  year: 2019
  ident: 10.1016/j.transproceed.2025.04.010_bib0023
  article-title: Evolution of the concept of quality of life in the population in end stage renal disease. A systematic review of the literature
  publication-title: Clin Ter
– volume: 73
  start-page: 1269
  year: 2002
  ident: 10.1016/j.transproceed.2025.04.010_bib0003
  article-title: Kidney graft failure and presensitization against HLA class I and class II antigens
  publication-title: Transplantation
  doi: 10.1097/00007890-200204270-00014
– volume: 36
  start-page: 2009
  year: 2004
  ident: 10.1016/j.transproceed.2025.04.010_bib0004
  article-title: Effect of panel-reactive antibody positivity on graft rejection before or after kidney transplantation
  publication-title: Transplant Proc
  doi: 10.1016/j.transproceed.2004.08.137
– volume: 56
  start-page: 6
  year: 1997
  ident: 10.1016/j.transproceed.2025.04.010_bib0002
  article-title: The role of HLA in renal transplantation
  publication-title: Hum Immunol
  doi: 10.1016/S0198-8859(97)00187-0
– volume: 146
  start-page: 11
  year: 2005
  ident: 10.1016/j.transproceed.2025.04.010_bib0006
  article-title: Kidney transplantation in the hyperimmunized patient
  publication-title: Contrib Nephrol
– volume: 28
  start-page: 127
  year: 2014
  ident: 10.1016/j.transproceed.2025.04.010_bib0010
  article-title: Clinical outcomes among renal transplant recipients with pre-transplant weakly reactive donor-specific antibodies
  publication-title: Clin Transplant
  doi: 10.1111/ctr.12289
– volume: 35
  year: 2022
  ident: 10.1016/j.transproceed.2025.04.010_bib0012
  article-title: European Guideline for the Management of kidney Transplant patients with HLA antibodies: by the European Society for Organ Transplantation Working Group
  publication-title: Transpl Int
  doi: 10.3389/ti.2022.10511
– volume: 93
  start-page: 491
  year: 2018
  ident: 10.1016/j.transproceed.2025.04.010_bib0018
  article-title: Kidney allocation based on proven acceptable antigens results in superior graft survival in highly sensitized patients
  publication-title: Kidney Int
  doi: 10.1016/j.kint.2017.07.018
– volume: 4
  year: 2023
  ident: 10.1016/j.transproceed.2025.04.010_bib0011
  article-title: Novel insights in the clinical management of highly sensitized patients before and after transplantation
  publication-title: Curr Res Immunol
  doi: 10.1016/j.crimmu.2023.100056
– volume: 21
  year: 2007
  ident: 10.1016/j.transproceed.2025.04.010_bib0001
  article-title: Detection and analysis of HLA class I and class II specific alloantibodies in the sera of dialysis recipients waiting for a renal retransplantation
  publication-title: Clin Transplant
  doi: 10.1111/j.1399-0012.2006.00578.x
– volume: 12
  year: 2021
  ident: 10.1016/j.transproceed.2025.04.010_bib0021
  article-title: Highly sensitized patients are well served by receiving a compatible organ offer based on acceptable mismatches
  publication-title: Front Immunol
  doi: 10.3389/fimmu.2021.687254
– volume: 21
  start-page: 135
  year: 2021
  ident: 10.1016/j.transproceed.2025.04.010_bib0026
  article-title: A review of imlifidase in solid organ transplantation
  publication-title: Expert Opin Biol Ther
  doi: 10.1080/14712598.2021.1850685
– ident: 10.1016/j.transproceed.2025.04.010_bib0014
– volume: 106
  start-page: 2448
  year: 2022
  ident: 10.1016/j.transproceed.2025.04.010_bib0020
  article-title: Impact of sensitization on waiting time prior to kidney transplantation in Germany
  publication-title: Transplantation
  doi: 10.1097/TP.0000000000004238
– volume: 68
  year: 2021
  ident: 10.1016/j.transproceed.2025.04.010_bib0016
  article-title: Disparity in the access to kidney transplantation for highly sensitized patients in the state of Sao Paulo-Brazil
  publication-title: Transpl Immunol
  doi: 10.1016/j.trim.2021.101441
– volume: 19
  start-page: 2926
  year: 2019
  ident: 10.1016/j.transproceed.2025.04.010_bib0019
  article-title: Allocation to highly sensitized patients based on acceptable mismatches results in low rejection rates comparable to non-highly sensitized patients
  publication-title: Am J Transplant
  doi: 10.1111/ajt.15486
– ident: 10.1016/j.transproceed.2025.04.010_bib0022
– volume: 10
  start-page: 26
  year: 2010
  ident: 10.1016/j.transproceed.2025.04.010_bib0008
  article-title: Calculated PRA (CPRA): the new measure of sensitization for transplant candidates
  publication-title: Am J Transplant
  doi: 10.1111/j.1600-6143.2009.02927.x
SSID ssj0004243
Score 2.425823
Snippet HLA sensitization plays a pivotal role in kidney transplantation. The presence of anti HLA antibodies strongly limits access to transplantation to subjects on...
SourceID proquest
pubmed
crossref
elsevier
SourceType Aggregation Database
Index Database
Publisher
StartPage 975
SubjectTerms Adult
Female
Histocompatibility
Histocompatibility Testing
HLA Antigens - immunology
Humans
Italy
Kaplan-Meier Estimate
Kidney Transplantation - adverse effects
Kidney Transplantation - mortality
Male
Middle Aged
Retrospective Studies
Time Factors
Waiting Lists - mortality
Title Survival of Highly Sensitized Patients on the Waiting List for Kidney Transplantation at Modena Transplant Center
URI https://www.clinicalkey.com/#!/content/1-s2.0-S0041134525002799
https://dx.doi.org/10.1016/j.transproceed.2025.04.010
https://www.ncbi.nlm.nih.gov/pubmed/40562598
https://www.proquest.com/docview/3224256347
Volume 57
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3PT9swFH5CTEi7TBuMrWxDD2niREZcJ2miaYcODZUxEBKdxs1yHEcKApfR9JAd9rfv2Y4Lk4aEtFt_WU37nj9_z_neZ4D3uqxrPdI84jyjAiWlqUgspI5oTsqKVSqP3WkNJ6fZ5Hvy9SK9WIGD0AtjZZU99ntMd2jdv7Lf_5v7N01je3wTxri7L0e1VWGb-Kx7HeX0h993Mo9kGJRzLLKfDsajTuPVOgNxv1JQrThMne2p7ab99yL1EAl1i9Hhc3jWs0gc-wt9ASvarMPG2FAFfd3hLjpdp9swX4e1z-HR7pn3qe72cHrXdjXfcwOWDtbdBvw8XxCCUA7irEarBLnq8Nwq3dvml67wzHuxznFmkPgj_pCNFU_jN0oZJBKMx01ldIfeOP1K-u4mg7JFe_SakffeQbu9rG9fwvTwy_RgEvVnM0SKp1bQQVRNV1pyOaIiZljEFdWWaqTqXLNyWNaslInKeB0rQnad5hkxCamKvGCKxZXkm7BqZka_BpSsqHRst16YJDQp80xJZXmjTEpF9dQAeIiFuPEOHCJI0y7F_QgKG0ERJ4IiOICPIWwi9JgSKgpaKB41-tNy9F_Z-OjxOyFTBE1Xew9GGj1bzAXhJ6FkxpPRAF75FFr-qiR21Wi-9Z_f_gae2mdeVPwWVtvbhX5H1Kktt93c2IYn46PjyekfYEwb8w
linkProvider Elsevier
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3fa9RAEB7qFdEXqa3W06ojSJ8amr1Ncgniw1ksV-96FHpi35bNZgORuld7uYf41zu7m1xbqFDwLSQM-TGz336z-WYW4KPOy1IPNQ84TyhBiWkoEgspAxqTsmCFSkO3W8PpLBl_j75dxBcbcNTVwlhZZYv9HtMdWrdnDtuveXhVVbbGN2KMu_9ylFtl2SPYtN2poh5sjk4m49lNeeSgE8-xwBp0vUedzKt2PcT9ZEHp4iB2nU9tQe3989S_eKibj4634FlLJHHkn_U5bGizDTsjQ0n0rwb30Uk73Zr5Njz-0h3tn_lW1c0Bzm8qr5YHzmDdxLrZgd_nKwIRCkNclGjFIJcNnluxe1390QWe-XasS1wYJAqJP2Rl9dM4pahB4sE4qQqjG_S90y-lL3AyKGu0u68ZeesK2hVmff0C5sdf50fjoN2eIVA8tpoOYmu60JLLIeUxgywsKL1UQ1WmmuWDvGS5jFTCy1ARuOs4TYhMSJWlGVMsLCR_CT2zMPoVoGRZoUO7-sIkAUqeJkoqSx1llCtKqfrAO1-IK9-EQ3TqtJ_itgeF9aAII0Ee7MOnzm2iKzMlYBQ0VzzI-vPa-k5APtj-Qxcpgkas_Q0jjV6sloIglIAy4dGwD7s-hNZvFYUuIU1f_-fd38OT8fx0KqYns8kbeGqveI3xHvTq65V-S0yqzt-1I-UvAFMepA
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Survival+of+Highly+Sensitized+Patients+on+the+Waiting+List+for+Kidney+Transplantation+at+Modena+Transplant+Center&rft.jtitle=Transplantation+proceedings&rft.au=Mori%2C+Giacomo&rft.au=Plessi%2C+Jessica&rft.au=Morisi%2C+Niccol%C3%B2&rft.au=Tonelli%2C+Laura&rft.date=2025-07-01&rft.issn=0041-1345&rft.volume=57&rft.issue=6&rft.spage=975&rft.epage=981&rft_id=info:doi/10.1016%2Fj.transproceed.2025.04.010&rft.externalDBID=n%2Fa&rft.externalDocID=10_1016_j_transproceed_2025_04_010
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0041-1345&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0041-1345&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0041-1345&client=summon